Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study

BACKGROUND: The purpose of this study was to assess changes in gastrointestinal symptom severity in patients with autoimmune disease who were switched from mycophenolate mofetil to enteric-coated mycophenolate sodium (EC-MPS). METHODS: In this national, explorative, single-arm study, 111 patients we...

Descripción completa

Detalles Bibliográficos
Autores principales: Manger, Bernhard, Hiepe, Falk, Schneider, Matthias, Worm, Margitta, Wimmer, Peter, Paulus, Eva-Maria, Schwarting, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516030/
https://www.ncbi.nlm.nih.gov/pubmed/26229499
http://dx.doi.org/10.2147/CEG.S81922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516030/
https://www.ncbi.nlm.nih.gov/pubmed/26229499
http://dx.doi.org/10.2147/CEG.S81922

Ejemplares similares